IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported financial results for the third quarter of 2023.
- Revenues came in at $3.74 billion in the September quarter, which is up 4.9% from the prior-year quarter
- Third-quarter net Income, on a reported basis, increased 7.1% annually to $303 million; EPS rose 9.4% to $1.63
- Adjusted earnings per share, excluding special items, edged up 0.4% year-over-year to $2.49 per share
- Adjusted EBITDA was $888 million during the three-month period, up 9.1% year-over-year
- R&D Solutions quarterly bookings were $2.6 billion in Q3, representing a book-to-bill ratio of 1.24x
- There was an R&D solution contracted backlog of $28.8 billion, which is up 12% year-over-year
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
